Company News Room

International Isotopes, Inc. to Divest Depleted Uranium Deconversion Assets to American Fuel Resources for $12,500,000 Cash

Thursday, February 8, 2024

PR_DUF6 Asset Transaction_20240208_final.pdf

 

International Isotopes, Inc. Announces Fiscal Results for the Third Quarter and First Nine Months of 2023

Tuesday, November 14th, 2023

INIS 2023 3rd Q PR

 

International Isotopes, Inc. Announces Fiscal Results for the Second Quarter and First Six Months of 2023

Monday, August 14th, 2023

INIS 2023 2nd Q PR

 

International Isotopes, Inc. Announces Changes in Executive Officers and Directors

Tuesday, July 18th, 2023

INIS Change in Corporate Officers PR 7-17-23

 

International Isotopes, Inc. Announces the Acquisition of the AMICI Inc. Product Line

Wednesday, June 21st, 2023

AMICI Aquisition Press Release (R2)INIS 2023 1st Q PR

 

International Isotopes, Inc. Announces Financial Results for the First Quarter 2023

Tuesday, May 16th, 2023

INIS 2023 1st Q PR

 

International Isotopes, Inc. Announces the Appointment of Shahe Bagerdjian as President

Monday, May 8th, 2023

Shahe Bagerdjian Press Release

 

International Isotopes, Inc. Announces 2022 Year End Financial Results

Thursday, April 6th, 2023

INIS – 2022 10K Earning Release

 

INIS Announces Financial Results For The Third Quarter and The First Nine Months 2022

Wednesday, November 16th, 2022

INIS 2022 3rd Q PR

 

INIS Announces Financial Results For The Second Quarter And Six Months 2022

Tuesday, August 16th, 2022

INIS 2022 2nd Q 6mo PR

 

INIS Announces Financial Results For The First Quarter 2022

Tuesday, May 17th, 2022

INIS 2022 1st Q PR

 

INIS Announces 2021 Year End Financial Results

Monday, April 4th, 2022

INIS 2021 10 Earnings Release

 

INIS Announces Completion Of An Asset Purchase Agreement With Pharmalogic Holdings Corp.

Tuesday, February 22nd, 2022

Pharmalogic APA Press Release

 

INIS Announces Approval Of Modification To Extend The Maturity Date Of Its Series C Preferred Stock

Thursday, February 17th, 2022

Preferred Series C Press Release

 

INIS Announces Exclusive Licensing Agreement For Commercialization Of A Radiolabeled Antibody Test For Detecting SARS CoV-2

Tuesday, December 7th, 2021

INIS Announces Exclusive Licensing Agreement For Commercialization Of A Radiolabeled Antibody Test For Detecting SARS CoV-2

 

INIS Announces It Has Acquired Full Ownership of RadQual LLC

Monday, July 12th, 2021

Radqual acquisition PR 7-12-21 (final)

 

INIS Announces a Collaboration with LEA for Distribution of Calibration Sources in North America

Tuesday, February 9th, 2021

INIS Announces a Collaboration with Laboratoire D’Etalons D’Activite (LEA) for Distribution of Calibration Sources in North America

 

International Isotopes Inc. Announces U.S. Food and Drug Administration Approval of Their ANDA for Sodium Iodide I-131

Monday, February 10th, 2020

FDA-Approval-Press-Release